ConductScience.org, home

Paper28875498

Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.

Kagami T and 10 others. Clin Pharmacol Ther, 2018. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype. Papers, record 28875498. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28875498

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
2018
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.72
iCite
Revised in PubMed
2022-12-07
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kagami TTakuma
2Yamade MMihoko
3Suzuki TTakahiro
4Uotani TTakahiro
5Hamaya YYasushi
6Iwaizumi MMoriya
7Osawa SSatoshi
8Sugimoto KKen
9Umemura KKazuo
10Miyajima HHiroaki
11Furuta TTakahisa

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PlateletsMajor topic
ClopidogrelMajor topic
Cytochrome P-450 CYP2C19Major topic
EsomeprazoleMajor topic
Platelet Aggregation InhibitorsMajor topic
Prasugrel HydrochlorideMajor topic
PyrrolesMajor topic
SulfonamidesMajor topic
Adult
Asian People
Drug Interactions
Female
Genotype
Humans
Male
Platelet Aggregation
Young Adult

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in29603200CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan.https://conductscience.org/library/papers/29603200PubMed
Comment in29663346Response to "CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan".https://conductscience.org/library/papers/29663346PubMed

Download CSV of comments and corrections

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42646320In Vivo Metabolite Formation and In Vitro Cytochrome P450-Mediated Metabolism of Vonoprazan in Horses.Metabolites2026https://conductscience.org/library/papers/42646320PubMed
42427013Effect of Low-Dose Vonoprazan on Hepatic Cytochrome P450 Activity By 13C-Aminopyrine Breath Test in Healthy Subjects.Med Sci Monit2026https://conductscience.org/library/papers/42427013PubMed
42316519Management of Peptic Ulcer Disease in Patients Taking Antithrombotic Agents.Korean J Helicobacter Up Gastrointest Res2026https://conductscience.org/library/papers/42316519PubMed
42220767Vonoprazan vs Proton Pump Inhibitors for Gastroprotection in Anticoagulated Patients: A Real-World Cohort Study.Cureus2026https://conductscience.org/library/papers/42220767PubMed
41368631Recent advances in gut microbiota metabolite regulation of hepatic pregnane X receptor.Front Immunol2025https://conductscience.org/library/papers/41368631PubMed
40117040Comparative effectiveness of potassium-competitive acid blockers and proton pump inhibitors in dual antiplatelet therapy patients: a nationwide cohort study.Int J Clin Pharm2025https://conductscience.org/library/papers/40117040PubMed
39145848Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments.Curr Gastroenterol Rep2024https://conductscience.org/library/papers/39145848PubMed
38751605P-CAB versus PPI in the eradication of Helicobacter pylori: a systematic review and network meta-analysis.Ther Adv Gastroenterol2024https://conductscience.org/library/papers/38751605PubMed
37176551Expectations for the Dual Therapy with Vonoprazan and Amoxicillin for the Eradication of H. pylori.J Clin Med2023https://conductscience.org/library/papers/37176551PubMed
36897544Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.Clin Pharmacokinet2023https://conductscience.org/library/papers/36897544PubMed
35445847Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel : Influence of alternate-day dosing of vonoprazan.Eur J Clin Pharmacol2022https://conductscience.org/library/papers/35445847PubMed
35146797Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.Br J Clin Pharmacol2022https://conductscience.org/library/papers/35146797PubMed
34867368Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects.Front Pharmacol2021https://conductscience.org/library/papers/34867368PubMed
33774763Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis.Int J Clin Pharm2021https://conductscience.org/library/papers/33774763PubMed
33693287Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y12 Assay in Patients With Coronary Artery Disease.Circ Rep2020https://conductscience.org/library/papers/33693287PubMed
33575950Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.Adv Ther2021https://conductscience.org/library/papers/33575950PubMed
32581516Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats.Drug Des Devel Ther2020https://conductscience.org/library/papers/32581516PubMed
32116727Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo.Front Pharmacol2020https://conductscience.org/library/papers/32116727PubMed
31267433Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy.Clin Drug Investig2019https://conductscience.org/library/papers/31267433PubMed
30993551Inhibitory Effect of Vonoprazan on the Metabolism of [14C]Prasugrel in Human Liver Microsomes.Eur J Drug Metab Pharmacokinet2019https://conductscience.org/library/papers/30993551PubMed

See all 24 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2C191557PubTator's text mininghttps://conductscience.org/library/genes/1557NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
P2RY1264805PubTator's text mininghttps://conductscience.org/library/genes/64805NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28875498

GET https://conductscience.org/api/papers/v1/28875498/cited_by?page=2